Viridian Therapeutics
VRDN
$13.45
Share price
-8.07%
Change (1 day)
-41.29%
Change (1 year)
Categories
Operating Margin for Viridian Therapeutics (VRDN)
Operating Margin as of May 2024 (TTM): -7,312.86%
According to Viridian Therapeutics's latest financial reports and stock price the company's current Operating Margin is -7,312.86%. At the end of 2021 the company had an Operating Margin of -2,680.16%.
Operating Margin history for Viridian Therapeutics from 2013 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -2,680.16% | -74.58% |
| 2020 | -10,544.29% | 1023.35% |
| 2019 | -938.65% | 140.7% |
| 2018 | -389.97% | -41.12% |
| 2017 | -662.30% | 74.38% |
| 2016 | -379.80% | -14.91% |
| 2015 | -446.34% | 144.38% |
| 2014 | -182.64% | 265.04% |
| 2013 | -50.03% | -60.76% |
| 2012 | -127.51% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.